GLOBUS MEDICAL INC - A (GMED) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:GMED - US3795772082 - Common Stock
GMED Key Statistics, Chart & Performance
The current stock price of GMED is 91.04 USD. In the past month the price increased by 49.93%. In the past year, price increased by 6.34%.
GMED Latest News, Press Relases and Analysis
GMED Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.83 | 224.14B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.61 | 203.30B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.43 | 150.59B | ||
| SYK | STRYKER CORP | 28.18 | 141.95B | ||
| IDXX | IDEXX LABORATORIES INC | 59.7 | 60.12B | ||
| BDX | BECTON DICKINSON AND CO | 13.45 | 55.61B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.72 | 50.29B | ||
| RMD | RESMED INC | 25.84 | 37.34B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.43 | 36.44B | ||
| DXCM | DEXCOM INC | 34.12 | 24.89B | ||
| PODD | INSULET CORP | 71.6 | 23.02B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 12.05 | 19.33B |
Related stock screener links
About GMED
Company Profile
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 5,300 full-time employees. The company went IPO on 2012-03-08. The firm offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the conditions affecting the spine, including degenerative conditions, deformities, tumors, and trauma. The company provides solutions that facilitate both open and minimally invasive surgery techniques. The company includes traditional fusion implants, such as pedicle screws and rod systems, and others. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
Company Info
GLOBUS MEDICAL INC - A
2560 General Armistead Ave
Audubon PENNSYLVANIA 19403 US
CEO: David M. Demski
Employees: 5300
Phone: 16109301800
GLOBUS MEDICAL INC - A / GMED FAQ
What does GLOBUS MEDICAL INC - A do?
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 5,300 full-time employees. The company went IPO on 2012-03-08. The firm offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the conditions affecting the spine, including degenerative conditions, deformities, tumors, and trauma. The company provides solutions that facilitate both open and minimally invasive surgery techniques. The company includes traditional fusion implants, such as pedicle screws and rod systems, and others. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
What is the current price of GMED stock?
The current stock price of GMED is 91.04 USD. The price decreased by -0.04% in the last trading session.
What is the dividend status of GLOBUS MEDICAL INC - A?
GMED does not pay a dividend.
What is the ChartMill rating of GLOBUS MEDICAL INC - A stock?
GMED has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What sector and industry does GLOBUS MEDICAL INC - A belong to?
GLOBUS MEDICAL INC - A (GMED) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
How many employees does GLOBUS MEDICAL INC - A have?
GLOBUS MEDICAL INC - A (GMED) currently has 5300 employees.
Can you provide the upcoming earnings date for GLOBUS MEDICAL INC - A?
GLOBUS MEDICAL INC - A (GMED) will report earnings on 2026-02-10, after the market close.
GMED Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to GMED. When comparing the yearly performance of all stocks, GMED is one of the better performing stocks in the market, outperforming 88.23% of all stocks.
GMED Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to GMED. GMED scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
GMED Financial Highlights
Over the last trailing twelve months GMED reported a non-GAAP Earnings per Share(EPS) of 3.56. The EPS increased by 22.76% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 15.3% | ||
| ROA | 8.32% | ||
| ROE | 9.63% | ||
| Debt/Equity | 0 |
GMED Forecast & Estimates
21 analysts have analysed GMED and the average price target is 90.69 USD. This implies a price decrease of -0.39% is expected in the next year compared to the current price of 91.04.
For the next year, analysts expect an EPS growth of 4.11% and a revenue growth 14.02% for GMED